Institutional shares held 13.7 Million
21.9K calls
2.6K puts
Total value of holdings $13.7M
$21K calls
$2K puts
Market Cap $33M
32,651,800 Shares Out.
Institutional ownership 42.11%
# of Institutions 48


Latest Institutional Activity in SCYX

Top Purchases

Q3 2024
Amh Equity LTD Shares Held: 600K ($606K)
Q3 2024
Bridgeway Capital Management, LLC Shares Held: 423K ($427K)
Q3 2024
Geode Capital Management, LLC Shares Held: 399K ($403K)
Q3 2024
Xtx Topco LTD Shares Held: 17.1K ($17.3K)
Q3 2024
Ubs Oconnor LLC Shares Held: 160K ($162K)

Top Sells

Q3 2024
Federated Hermes, Inc. Shares Held: 3.6M ($3.63M)
Q3 2024
D.A. Davidson & Co. Shares Held: 528K ($533K)
Q3 2024
O'Shaughnessy Asset Management, LLC Shares Held: 14.9K ($15.1K)
Q3 2024
Wealth Effects LLC Shares Held: 102K ($103K)
Q3 2024
Morgan Stanley Shares Held: 15.7K ($15.9K)

About SCYX

SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including recurrent VVC, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections; and ibrexafungerp that has completed Phase 3 CANDLE study for the prevention of recurrent (VVC). It has research collaborations with Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, and R-Pharm, CJSC to develop and commercialize rights for ibrexafungerp. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.


Insider Transactions at SCYX

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
736K Shares
From 10 Insiders
Grant, award, or other acquisition 716K shares
Open market or private purchase 20K shares
Sell / Disposition
15.2K Shares
From 1 Insiders
Payment of exercise price or tax liability 15.2K shares

Track Institutional and Insider Activities on SCYX

Follow SCYNEXIS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SCYX shares.

Notify only if

Insider Trading

Get notified when an Scynexis Inc insider buys or sells SCYX shares.

Notify only if

News

Receive news related to SCYNEXIS INC

Track Activities on SCYX